2014 annual financial data
ProQR Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -4,618.85%.
Operating income was -16,461,000 EUR and net income was -12,127,000 EUR.
Operating cash flow was -14,457,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 313,000 EUR
- Operating income
- -16,461,000 EUR
- Net income
- -12,127,000 EUR
- Operating cash flow
- -14,457,000 EUR